Latest biotechnology News | Page 25

Longtermism – why the million-year philosophy can’t be ignored
Positive CHMP Opinion Etranacogene Dezaparvovec
Wisner ’16 shares expertise with entrepreneurial community
ARCS Signature Program launched for senior leaders
New Study Sheds Light on Boric Acid Transport and Excretion in Marine Fish
CSIRO announces successful ON Accelerate teams
Major industry award for Australian scientist at forefront of genetic breast cancer research
CSL announces appointment of its new CEO and managing director
CSL Announces Next CEO & Managing Director
CSL Closing of Arcturus Therapeutics Agreement
CSL’s Novel Gene Therapy HEMGENIX Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living
Associate Professor Ayuko Hoshino Receives NAM Healthy Longevity QuickFire Challenge Award
Targeted photothermal treatment for blood clots shows promise
International coup for food crop research
Novotech awarded Asia Pacific CRO of Year 2022 for ‘Best Practices in Clinical Trials’
CSL opens its new ‘Australian Plasma Fractionation Facility’ in Melbourne
Nominations open for PM’s Prizes for Science
New Australian Plasma Fractionation Facility
Noxopharm provides update on trial of its oncology drug candidate
Vaxxas appoints Doug Cubbin as its new chief financial officer
Contributions now open for upcoming Australasian Biotechnology’
Why synonymous mutations are not always silent
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
WEHI scientist recognised with CSL Florey Medal for malaria research
Developer announces plans for new medical research facility in Brisbane
National Reconstruction Fund takes step forward
Discovery suggests new way to target mantle cell lymphoma
AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
Immutep announces new collaboration for cancer treatment combination
Emyria accepted into US National Institutes of Health research program
Sonic Healthcare takes major strategic stake in Microba
Artificial intelligence high on life sciences’ agenda
ARC Training Centre is ensuring digital security for all Australians
Australian venture capital fund joins partners in backing new immunotherapy
CSL secures US approval for breakthrough one-time haemophilia gene therapy
AusBiotech gets behind campaign to combat ‘silent pandemic’
Bacteria use ancient mechanisms to self-repair
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
IND approval from US FDA for theranostic SARBombesin trial in prostate cancer
Zelira Therapeutics announces successful enrolment in new trial Zelira Therapeutics
Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia
AusBiotech Policy Forum: Biotech leaders head to Parliament
UNSW solar innovator, world-leading oceanographer and molecular tech entrepreneurs awarded Prime Minister’s Prizes for Science
Moderna scientist to speak about COVID vaccine development
AusBiotech connects sector to celebrate 2022
ARC Research Hub will address environmental impacts of waste production
Telix acquires US radiochemistry business Optimal Tracers
Commercialisation key priority in future MRFF decisions